Sept. 14, 2009 – Abbott said today the Chinese State Food and Drug Administration (SFDA) has approved the XIENCE ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
Gregg W. Stone, M.D., offered a preview Sept. 10 of some of the key, late-breaking clinical trials and trends in ...
September 3, 2009 – Abbott said last week it received approval from Health Canada for the XIENCE V Everolimus ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
September 2, 2009 – Abbott announced Monday at the European Society of Cardiology Congress the widespread ...
September 1, 2009 – Cordis Corp. said first patient has been enrolled in the CYPRESS study, which will assess ...
August 31, 2009 – IDEV Technologies Inc. announced last week the first patient was enrolled in the company's FDA ...
August 24, 2009 – Prescient Medical Inc. said today it received European CE mark clearance to commercialize its ...
August 13, 2009 – Abbott today announced the expansion of the company's XIENCE V USA post-approval study designed ...
August 11, 2009 – Physicians in the United Kingdom yesterday completed patient implants using the first CE mark ...
July 29, 2009 – Medtronic Inc. said earlier this week it has reached a settlement with Abbott Laboratories over ...
July 27, 2009 – Prescient Medical Inc. received the prestigious 2009 North American Product Innovation of the ...
July 22, 2009 – W. L. Gore & Associates today said it received FDA approval to market its GORE VIABAHN ...
When stenting emerged as a minimally- invasive treatment for clogged arteries associated with peripheral artery ...
July 16, 2009 – Boston Scientific Corp. today said its received approval from the FDA to market its TAXUS Liberte ...
July 14, 2009 – Despite the fact that drug-eluting stent (DES) implantation reduces restenosis and the need for ...